世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

神経認知評価とリハビリテーションの市場規模、シェア、動向分析レポート：コンポーネント別（神経認知評価テスト、神経リハビリテーション療法）、プロバイダー別（リハビリセンター、病院、クリニック）、地域別、セグメント別予測、2024年～2030年


Neurocognitive Assessment And Rehabilitation Market Size, Share & Trends Analysis Report By Component (Neurocognitive Assessment Testing, Neurorehabilitation Therapy), By Providers (Rehab Centers, Hospital And Clinics), By Region, And Segment Forecasts, 2024 - 2030

神経認知評価とリハビリテーション市場の成長と動向 Grand View Research社の最新レポートによると、世界の神経認知評価とリハビリテーション市場は2030年までに246億ドルに達すると予測され、2024年から2030... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ 		2023年12月11日 US$5,950
シングルユーザライセンス（印刷不可）
ライセンス・価格情報
注文方法はこちら 		145 英語

本レポートは受注生産のため、ご納品のお時間をいただく場合がございます。


　

サマリー

神経認知評価とリハビリテーション市場の成長と動向

Grand View Research社の最新レポートによると、世界の神経認知評価とリハビリテーション市場は2030年までに246億ドルに達すると予測され、2024年から2030年までのCAGRは8.67％で拡大すると予測されている。同市場の成長の背景には、世界的な認知症患者の増加がある。世界人口の増加と、それに伴う認知症患者の増加に伴い、認知症の状態を管理し、認知機能をできるだけ長く維持するための効果的な神経認知評価とリハビリテーションの必要性が高まっている。国連の世界人口見通し報告書によると、2050年までに世界全体で65歳以上の人口は6人に1人（16％）となり、2019年の11人に1人（9％）から増加する。

また、認知症は世界的に主要な神経疾患のひとつになると予想されている。WHOによると、世界で約5500万人が認知症であり、その60％以上が低・中所得国に居住している。ほぼすべての国で人口に占める高齢者の割合が増加しているため、この数は2030年には7800万人、2050年には1億3900万人に増加すると予想されている。

さらに、神経障害に関連する研究活動における政府のイニシアチブの高まりは、市場の成長を促進すると予想される。例えば、英国政府は2021年11月、様々な神経変性疾患の理解と治療を改善するプロジェクトに資金を提供するため、今後5年間で4億7,000万米ドルを投資すると発表した。この疾患には、運動ニューロン疾患（MND）、パーキンソン病、認知症、レビー小体型認知症（LBD）などが含まれる。

神経認知評価とリハビリテーション市場レポートハイライト

- 構成要素に基づき、市場は神経認知評価検査と神経リハビリテーション療法に分けられる。神経リハビリテーション療法分野は、神経疾患の高い有病率、老年人口の増加、神経リハビリテーション機器の技術開発により、2023年の収益シェアが62%を超え、市場を支配している。

- プロバイダー別に見ると、市場はリハビリセンター、病院・診療所、在宅ケア環境、理学療法センターに分けられる。2023年にはリハビリセンター分野が市場を支配した。これは、技術の著しい進歩により、リハビリセンターが各患者固有の要件に合わせたより個別化された治療計画を提供できるようになったためである。

- 北米が神経認知評価およびリハビリテーション市場を支配したのは、医療分野における研究開発の重視などの要因によるものである。この地域は、研究機関、医療系大学、民間企業による強固なエコシステムが構築されているため、神経認知技術の継続的なイノベーションが促進されると期待されている。

- 2023年6月、コグネティヴィティ・ニューロサイエンシズはClairvoと協業し、日本を含むアジア太平洋地域でAIを活用した脳の健康管理を強化した。この協業により、CognetivityのAIプラットフォームの導入が加速し、同地域における脳の健康に対する認識が促進されることが期待される。

ページTOPに戻る


目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Component
1.2.2. Providers
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Volume Price Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.2.1. Component Outlook
2.2.2. Providers Outlook
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Prevalence of Neurological Disorders
3.2.1.2. Technological Advancement
3.2.1.3. Rising Government Initiatives and Funding
3.2.2. Market Restraint Analysis
3.2.2.1. High Cost of Technologies and Services
3.2.2.2. Shortage of Trained Professionals
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
Chapter 4. Component Business Analysis
4.1. Component Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Neurocognitive Assessment and Rehabilitation Market by Component Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Neurocognitive Assessment Testing
4.4.1.1. Neurocognitive Assessment Testing Market, 2018 - 2030 (USD Million)
4.4.2. Neurorehabilitation Therapy
4.4.2.1. Neurorehabilitation Therapy Market, 2018 - 2030 (USD Million)
Chapter 5. Providers Business Analysis
5.1. Providers Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Neurocognitive Assessment and Rehabilitation Market by Providers Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Rehab Centers
5.4.1.1. Rehab Centers Market, 2018 - 2030 (USD Million)
5.4.2. Hospital and Clinics
5.4.2.1. Hospital and Clinics Market, 2018 - 2030 (USD Million)
5.4.3. Homecare Settings
5.4.3.1. Homecare Settings Market, 2018 - 2030 (USD Million)
5.4.4. Physiotherapy Centers
5.4.4.1. Physiotherapy Centers Market, 2018 - 2030 (USD Million)
Chapter 6. Regional Business Analysis
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Global Regional Market Snapshot
6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Target Population Analysis
6.4.2.2. Regulatory Landscape
6.4.2.3. Competitive Insights
6.4.2.4. U.S. Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Target Population Analysis
6.4.3.2. Regulatory Landscape
6.4.3.3. Competitive Insights
6.4.3.4. Canada Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.5.2. Germany
6.5.2.1. Target Population Analysis
6.5.2.2. Regulatory Landscape
6.5.2.3. Competitive Insights
6.5.2.4. Germany Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.5.3. UK
6.5.3.1. Target Population Analysis
6.5.3.2. Regulatory Landscape
6.5.3.3. Competitive Insights
6.5.3.4. UK Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Target Population Analysis
6.5.4.2. Regulatory Landscape
6.5.4.3. Competitive Insights
6.5.4.4. France Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Target Population Analysis
6.5.5.2. Regulatory Landscape
6.5.5.3. Competitive Insights
6.5.5.4. Italy Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Target Population Analysis
6.5.6.2. Regulatory Landscape
6.5.6.3. Competitive Insights
6.5.6.4. Spain Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.5.7. Denmark
6.5.7.1. Target Population Analysis
6.5.7.2. Regulatory Landscape
6.5.7.3. Competitive Insights
6.5.7.4. Denmark Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.5.8. Sweden
6.5.8.1. Target Population Analysis
6.5.8.2. Regulatory Landscape
6.5.8.3. Competitive Insights
6.5.8.4. Sweden Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.5.9. Norway
6.5.9.1. Target Population Analysis
6.5.9.2. Regulatory Landscape
6.5.9.3. Competitive Insights
6.5.9.4. Norway Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.2.1. Asia Pacific Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Target Population Analysis
6.6.2.2. Regulatory Landscape
6.6.2.3. Competitive Insights
6.6.2.4. Japan Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Target Population Analysis
6.6.3.2. Regulatory Landscape
6.6.3.3. Competitive Insights
6.6.3.4. China Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Target Population Analysis
6.6.4.2. Regulatory Landscape
6.6.4.3. Competitive Insights
6.6.4.4. India Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.6.5. South Korea
6.6.5.1. Target Population Analysis
6.6.5.2. Regulatory Landscape
6.6.5.3. Competitive Insights
6.6.5.4. South Korea Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.6.6. Australia
6.6.6.1. Target Population Analysis
6.6.6.2. Regulatory Landscape
6.6.6.3. Competitive Insights
6.6.6.4. Australia Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Target Population Analysis
6.6.7.2. Regulatory Landscape
6.6.7.3. Competitive Insights
6.6.7.4. Thailand Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Target Population Analysis
6.7.2.2. Regulatory Landscape
6.7.2.3. Competitive Insights
6.7.2.4. Brazil Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.7.3. Mexico
6.7.3.1. Target Population Analysis
6.7.3.2. Regulatory Landscape
6.7.3.3. Competitive Insights
6.7.3.4. Mexico Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.7.4. Argentina
6.7.4.1. Target Population Analysis
6.7.4.2. Regulatory Landscape
6.7.4.3. Competitive Insights
6.7.4.4. Argentina Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.8. MEA
6.8.1. MEA Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Target Population Analysis
6.8.2.2. Regulatory Landscape
6.8.2.3. Competitive Insights
6.8.2.4. South Africa Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Target Population Analysis
6.8.3.2. Regulatory Landscape
6.8.3.3. Competitive Insights
6.8.3.4. Saudi Arabia Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Target Population Analysis
6.8.4.2. Regulatory Landscape
6.8.4.3. Competitive Insights
6.8.4.4. UAE Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Target Population Analysis
6.8.5.2. Regulatory Landscape
6.8.5.3. Competitive Insights
6.8.5.4. Kuwait Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Company Market Position Analysis
7.3. Strategy Mapping
7.3.1. Expansion
7.3.2. Partnership
7.3.3. Collaborations
7.3.4. Others
7.4. Company Profiles/Listing
7.4.1. Cambridge Cognition Ltd
7.4.1.1. Overview
7.4.1.2. Financial Performance
7.4.1.3. Service Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. CogniFit Inc
7.4.2.1. Overview
7.4.2.2. Financial Performance
7.4.2.3. Service Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Cogstate Ltd
7.4.3.1. Overview
7.4.3.2. Financial Performance
7.4.3.3. Service Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. CNS Vital Signs, LLC
7.4.4.1. Overview
7.4.4.2. Financial Performance
7.4.4.3. Service Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Posit Science
7.4.5.1. Overview
7.4.5.2. Financial Performance
7.4.5.3. Service Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. HAPPYneuron
7.4.6.1. Overview
7.4.6.2. Financial Performance
7.4.6.3. Service Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Constant Therapy Health
7.4.7.1. Overview
7.4.7.2. Financial Performance
7.4.7.3. Service Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. Neural Assembly Int AB
7.4.8.1. Overview
7.4.8.2. Financial Performance
7.4.8.3. Service Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. Lumos Labs
7.4.9.1. Overview
7.4.9.2. Financial Performance
7.4.9.3. Service Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. Cognetivity Neurosciences
7.4.10.1. Overview
7.4.10.2. Financial Performance
7.4.10.3. Service Benchmarking
7.4.10.4. Strategic Initiatives
7.4.11. SCHUHFRIED GmbH
7.4.11.1. Overview
7.4.11.2. Financial Performance
7.4.11.3. Service Benchmarking
7.4.11.4. Strategic Initiatives
7.4.12. NeuronUp
7.4.12.1. Overview
7.4.12.2. Financial Performance
7.4.12.3. Service Benchmarking
7.4.12.4. Strategic Initiatives
7.4.13. BrainCheck, Inc.
7.4.13.1. Overview
7.4.13.2. Financial Performance
7.4.13.3. Service Benchmarking
7.4.13.4. Strategic Initiatives





　

ページTOPに戻る


　

Summary

Neurocognitive Assessment And Rehabilitation Market Growth & Trends

The global neurocognitive assessment and rehabilitation market is anticipated to reach USD 24.6 billion by 2030 and is anticipated to expand at a CAGR of 8.67% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market's growth can be attributed to the rise in dementia cases globally. With rise in global population and a corresponding increase in the number of people living with dementia, there is a growing need for effective neurocognitive assessment and rehabilitation to help individuals manage their condition and maintain their cognitive function for as long as possible. By 2050, there will be 1 in 6 (16%) people over 65 globally, accounting for an increase from 1 in 11 (9%) in 2019, according to the UN World Population Prospects report.

In addition, dementia is expected to be one of the major neurological diseases globally. According to WHO, around 55 million individuals worldwide have dementia, and more than 60% of them reside in low- and middle-income nations. It is anticipated that this number will increase to 78 million in 2030 and 139 million in 2050 due to the fact that the share of older people in the population is rising in almost every country.

Furthermore, the rising government initiatives in research activities related to neurological disorders are expected to drive market growth. For instance, in November 2021, the UK government announced an investment of USD 470 million over the next 5 years to fund projects to improve the understanding and treatment of various neurodegenerative conditions. The conditions include Motor Neurone Disease (MND), Parkinson’s disease, dementia, and Lewy Body Dementia (LBD).

Neurocognitive Assessment And Rehabilitation Market Report Highlights

• Based on component, the market is divided into neurocognitive assessment testing and neurorehabilitation therapy. The neurorehabilitation therapy segment dominated the market with a revenue share of over 62% in 2023, owing to the high prevalence of neurological disorders, the rising geriatric population, and technological developments in neurorehabilitation devices.

• Based on providers, the market is divided into rehab centers, hospitals and clinics, home care settings, and physiotherapy centers. The rehab centers segment dominated the market in 2023. This is due to the significant advancements in technology that have enabled rehab centers to provide more personalized treatment plans tailored to the unique requirements of each patient.

• North America dominated the neurocognitive assessment and rehabilitation market owing to factors such as a strong emphasis on research & development in the healthcare sector. The region’s robust ecosystem of research institutions, medical universities, and private industry players is expected to foster continuous innovation in neurocognitive technologies.

• In June 2023, Cognetivity Neurosciences collaborated with Clairvo to enhance AI-powered brain health management in Japan and other regions in Asia Pacific. This collaboration is expected to accelerate the adoption of Cognetivity's AI platform and promote brain health awareness in the region.



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Component
1.2.2. Providers
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Volume Price Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.2.1. Component Outlook
2.2.2. Providers Outlook
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Prevalence of Neurological Disorders
3.2.1.2. Technological Advancement
3.2.1.3. Rising Government Initiatives and Funding
3.2.2. Market Restraint Analysis
3.2.2.1. High Cost of Technologies and Services
3.2.2.2. Shortage of Trained Professionals
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
Chapter 4. Component Business Analysis
4.1. Component Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Neurocognitive Assessment and Rehabilitation Market by Component Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Neurocognitive Assessment Testing
4.4.1.1. Neurocognitive Assessment Testing Market, 2018 - 2030 (USD Million)
4.4.2. Neurorehabilitation Therapy
4.4.2.1. Neurorehabilitation Therapy Market, 2018 - 2030 (USD Million)
Chapter 5. Providers Business Analysis
5.1. Providers Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Neurocognitive Assessment and Rehabilitation Market by Providers Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Rehab Centers
5.4.1.1. Rehab Centers Market, 2018 - 2030 (USD Million)
5.4.2. Hospital and Clinics
5.4.2.1. Hospital and Clinics Market, 2018 - 2030 (USD Million)
5.4.3. Homecare Settings
5.4.3.1. Homecare Settings Market, 2018 - 2030 (USD Million)
5.4.4. Physiotherapy Centers
5.4.4.1. Physiotherapy Centers Market, 2018 - 2030 (USD Million)
Chapter 6. Regional Business Analysis
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Global Regional Market Snapshot
6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Target Population Analysis
6.4.2.2. Regulatory Landscape
6.4.2.3. Competitive Insights
6.4.2.4. U.S. Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Target Population Analysis
6.4.3.2. Regulatory Landscape
6.4.3.3. Competitive Insights
6.4.3.4. Canada Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.5.2. Germany
6.5.2.1. Target Population Analysis
6.5.2.2. Regulatory Landscape
6.5.2.3. Competitive Insights
6.5.2.4. Germany Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.5.3. UK
6.5.3.1. Target Population Analysis
6.5.3.2. Regulatory Landscape
6.5.3.3. Competitive Insights
6.5.3.4. UK Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Target Population Analysis
6.5.4.2. Regulatory Landscape
6.5.4.3. Competitive Insights
6.5.4.4. France Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Target Population Analysis
6.5.5.2. Regulatory Landscape
6.5.5.3. Competitive Insights
6.5.5.4. Italy Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Target Population Analysis
6.5.6.2. Regulatory Landscape
6.5.6.3. Competitive Insights
6.5.6.4. Spain Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.5.7. Denmark
6.5.7.1. Target Population Analysis
6.5.7.2. Regulatory Landscape
6.5.7.3. Competitive Insights
6.5.7.4. Denmark Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.5.8. Sweden
6.5.8.1. Target Population Analysis
6.5.8.2. Regulatory Landscape
6.5.8.3. Competitive Insights
6.5.8.4. Sweden Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.5.9. Norway
6.5.9.1. Target Population Analysis
6.5.9.2. Regulatory Landscape
6.5.9.3. Competitive Insights
6.5.9.4. Norway Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.2.1. Asia Pacific Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Target Population Analysis
6.6.2.2. Regulatory Landscape
6.6.2.3. Competitive Insights
6.6.2.4. Japan Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Target Population Analysis
6.6.3.2. Regulatory Landscape
6.6.3.3. Competitive Insights
6.6.3.4. China Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Target Population Analysis
6.6.4.2. Regulatory Landscape
6.6.4.3. Competitive Insights
6.6.4.4. India Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.6.5. South Korea
6.6.5.1. Target Population Analysis
6.6.5.2. Regulatory Landscape
6.6.5.3. Competitive Insights
6.6.5.4. South Korea Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.6.6. Australia
6.6.6.1. Target Population Analysis
6.6.6.2. Regulatory Landscape
6.6.6.3. Competitive Insights
6.6.6.4. Australia Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Target Population Analysis
6.6.7.2. Regulatory Landscape
6.6.7.3. Competitive Insights
6.6.7.4. Thailand Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Target Population Analysis
6.7.2.2. Regulatory Landscape
6.7.2.3. Competitive Insights
6.7.2.4. Brazil Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.7.3. Mexico
6.7.3.1. Target Population Analysis
6.7.3.2. Regulatory Landscape
6.7.3.3. Competitive Insights
6.7.3.4. Mexico Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.7.4. Argentina
6.7.4.1. Target Population Analysis
6.7.4.2. Regulatory Landscape
6.7.4.3. Competitive Insights
6.7.4.4. Argentina Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.8. MEA
6.8.1. MEA Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Target Population Analysis
6.8.2.2. Regulatory Landscape
6.8.2.3. Competitive Insights
6.8.2.4. South Africa Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Target Population Analysis
6.8.3.2. Regulatory Landscape
6.8.3.3. Competitive Insights
6.8.3.4. Saudi Arabia Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Target Population Analysis
6.8.4.2. Regulatory Landscape
6.8.4.3. Competitive Insights
6.8.4.4. UAE Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Target Population Analysis
6.8.5.2. Regulatory Landscape
6.8.5.3. Competitive Insights
6.8.5.4. Kuwait Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Company Market Position Analysis
7.3. Strategy Mapping
7.3.1. Expansion
7.3.2. Partnership
7.3.3. Collaborations
7.3.4. Others
7.4. Company Profiles/Listing
7.4.1. Cambridge Cognition Ltd
7.4.1.1. Overview
7.4.1.2. Financial Performance
7.4.1.3. Service Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. CogniFit Inc
7.4.2.1. Overview
7.4.2.2. Financial Performance
7.4.2.3. Service Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Cogstate Ltd
7.4.3.1. Overview
7.4.3.2. Financial Performance
7.4.3.3. Service Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. CNS Vital Signs, LLC
7.4.4.1. Overview
7.4.4.2. Financial Performance
7.4.4.3. Service Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Posit Science
7.4.5.1. Overview
7.4.5.2. Financial Performance
7.4.5.3. Service Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. HAPPYneuron
7.4.6.1. Overview
7.4.6.2. Financial Performance
7.4.6.3. Service Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Constant Therapy Health
7.4.7.1. Overview
7.4.7.2. Financial Performance
7.4.7.3. Service Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. Neural Assembly Int AB
7.4.8.1. Overview
7.4.8.2. Financial Performance
7.4.8.3. Service Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. Lumos Labs
7.4.9.1. Overview
7.4.9.2. Financial Performance
7.4.9.3. Service Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. Cognetivity Neurosciences
7.4.10.1. Overview
7.4.10.2. Financial Performance
7.4.10.3. Service Benchmarking
7.4.10.4. Strategic Initiatives
7.4.11. SCHUHFRIED GmbH
7.4.11.1. Overview
7.4.11.2. Financial Performance
7.4.11.3. Service Benchmarking
7.4.11.4. Strategic Initiatives
7.4.12. NeuronUp
7.4.12.1. Overview
7.4.12.2. Financial Performance
7.4.12.3. Service Benchmarking
7.4.12.4. Strategic Initiatives
7.4.13. BrainCheck, Inc.
7.4.13.1. Overview
7.4.13.2. Financial Performance
7.4.13.3. Service Benchmarking
7.4.13.4. Strategic Initiatives





　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

Grand View Research社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD（assessment）の最新刊レポート


よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ（Grand View Research）は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/23　10:26

157.72 円

164.94 円

201.11 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.